Brain structure and function as mediators of the effects of amyloid on memory
Authors:
- Niklas MattssonNMNiklas Mattsson
- Philip S. InselPIPhilip S. Insel
- Paul S. AisenPAPaul S. Aisen
- William JagustWJWilliam Jagust
- Scott MackinSMScott Mackin
- Michael WeinerMWMichael Weiner
- 17 March 2015
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 84 (11) , 1136-1144
Abstract
Objective: The objective of this study was to test whether effects of β-amyloid (Aβ) pathology on episodic memory were mediated by metabolism and gray matter volume in the early stages of Alzheimer disease. Methods: This was a prospective cohort study. We measured baseline Aβ (using florbetapir-PET), brain function (using fluorodeoxyglucose-PET), and brain structure (using MRI). A mediation analysis was performed to test whether statistical effects of Aβ positivity on cross-sectional and longitudinal episodic memory were mediated by hypometabolism or regional gray matter volume in cognitively healthy controls (CN, n = 280) and mild cognitive impairment (MCI, n = 463). Results: Lower memory scores were associated with Aβ positivity (CN, mildly; MCI, strongly), smaller gray matter volumes (CN, few regions, including hippocampus; MCI, widespread), and hypometabolism. Smaller volumes and hypometabolism mediated effects of Aβ in MCI but not in CN. The strongest individual regions mediated up to approximately 25%. A combination of brain structure and function mediated up to approximately 40%. In several regions, gray matter atrophy and hypometabolism predicted episodic memory without being associated (at p < 0.05) with Aβ positivity. Conclusions: Changes in brain structure and function appear to be, in part, downstream events from Aβ pathology, ultimately resulting in episodic memory deficits. However, Aβ pathology is also strongly related to memory deficits through mechanisms that are not quantified by these imaging measurements, and episodic memory decline is partly caused by Alzheimer disease–like brain changes independently of Aβ pathology.Keywords
This publication has 41 references indexed in Scilit:
- β-Amyloid burden in healthy agingNeurology, 2012
- Amyloid‐β associated cortical thinning in clinically normal elderlyAnnals of Neurology, 2010
- Cognition, reserve, and amyloid deposition in normal agingAnnals of Neurology, 2010
- The neuropathology of probable Alzheimer disease and mild cognitive impairmentAnnals of Neurology, 2009
- Decreased cerebrospinal fluid Aβ42 correlates with brain atrophy in cognitively normal elderlyAnnals of Neurology, 2009
- Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjectsBrain, 2008
- Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the ElderlyArchives of Neurology, 2008
- Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotypeNeurology, 2008
- The Alzheimer's disease neuroimaging initiative (ADNI): MRI methodsJournal of Magnetic Resonance Imaging, 2008
- Mediation AnalysisAnnual Review of Psychology, 2007